Market Trends of Spain Respiratory Devices Industry
This section covers the major market trends shaping the Spain Respiratory Devices Market according to our research experts:
Inhalers as Therapeutic Devices is Expected to Witness a Significant Growth Over the Forecast Period.
Respiratory inhalers are used to inhale medicines that are an essential part of the treatment for chronic lung diseases. Numerous products deliver medicine directly to the airways such as dry powder inhalers, metered-dose inhalers (MDIs), and soft mist inhalers. The factor that is driving the growth of this segment is the increasing prevalence of respiratory disorders in Spain. In addition, the increasing demand for treatment options for respiratory disorders and the accessibility of well-developed technologies are also contributing to the growth of this segment in Spain.
Furthermore, the increase in air pollution levels in Spain is increasing the cases of respiratory disorders, thereby increasing the demand for respiratory inhalers. For instance, in August 2022, EuroNews.green reported that higher concentrations of nitrogen oxide from increased traffic in Spain and Italy. Being exposed to high amounts of air pollution raises the risk of developing respiratory infections, illnesses, and cancer of the lung, among other health problems. As a result, the rising prevalence of respiratory diseases in Spain is driving up demand for inhalers and fueling the expansion of the market under study.
The increasing number of initiatives undertaken by the government of Spain to stop respiratory diseases by spreading awareness regarding the symptoms and the easy availability of new treatments are offering significant growth opportunities for this segment. For instance, in April 2022, the EFA reported that governments in European countries, including Spain alongside the GINA to further develop patient guidelines for asthma patients and their carers to increase asthma patients' empowerment for better self-management and adherence to their care.The goal of this initiative is to argue for the funding and resources necessary to provide Europeans with asthma, allergies, and COPD with care that is prompt, convenient, and cutting-edge. Asthma and chronic obstructive pulmonary disease (COPD) patients are a target population for government programmes that attempt to care for them by providing them with respiratory devices in a timely fashion, and these programmes are driving the expansion of this market.
Thus, due to the rising cases of respiratory disorders in Spain, increasing air pollution and technological advancements are increasing the demand for inhalers, thereby driving the growth of this segment.
Sleep Test Devices Under Diagnostic and Monitoring Devices is Expected to Witness a Significant Growth Over the Forecast Period.
Over the next few years, the market for sleep testing devices is predicted to expand significantly due to factors such the rising number of people who are overweight or obese and the prevalence of respiratory disorders, as well as the introduction of innovative new products. A rising number of Spanish citizens are becoming overweight, which is a key factor in the market's expansion over the time under analysis. Sleep test devices are designed to monitor an individual's sleep because of the increased likelihood of obstructive sleep apnea in obese people due to the presence of excess tissue in the back of the throat. As a result, there has been a rise in the need for sleep testing equipment due to the epidemic of obesity.
Similarly, the rising prevalence of sleep-disordered breathing (SDB) like snoring, obstructive sleep apnoea/hypopnea syndrome (OSAHS), central sleep apnoea (CSA), and hypoventilation syndromes are also contributing to the growth of this segment. For instance, an article published in ADB, in January 2022, reported rising cases of sleep disorders among the geriatric population of Spain. Thus, rising cases of sleep disorders are driving the demand for sleep test devices, thereby contributing to the segment's growth.
Furthermore, new product launches and other market strategies of key market players are driving the growth of this segment. For instance, in October 2022, a European company Acurable introduced AcuPebble SA100, it is a wearable medical device to obtain a CE mark in Europe for the automated diagnosis of obstructive sleep apnoea at home. Improvements in treatment for sleep problems brought about by these innovations are fueling the sector. As a result, rising rates of obesity and sleep apnea, as well as the introduction of innovative new products, are fueling this sector's expansion.
